This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:diseases:celiac [07.19.2019] – [recent research] sallieq | home:diseases:celiac [07.20.2019] – [recent research] sallieq | ||
---|---|---|---|
Line 69: | Line 69: | ||
In 2015 I saw that 6 individuals in the USA were suing maker of Benicar. (// | In 2015 I saw that 6 individuals in the USA were suing maker of Benicar. (// | ||
+ | |||
+ | Gluten in " | ||
+ | |||
2018 data show that OLM is an Nrf2 activator, NFkB inhibitor and apoptosis inhibitor in an experimental model of ulcerative colitis. Overall, the study indicates that OLM shows promise as a potential therapy for the treatment of human inflammatory bowel diseases. | 2018 data show that OLM is an Nrf2 activator, NFkB inhibitor and apoptosis inhibitor in an experimental model of ulcerative colitis. Overall, the study indicates that OLM shows promise as a potential therapy for the treatment of human inflammatory bowel diseases. |